Never Miss Important Company Updates Again

Get AI-powered summaries of SEC filings delivered to your inbox

Follow your favorite stocks and get email alerts when they release important updates. Completely free.

Covers 5,000+ public companies
Get started →
Sign up to stay up to date with the stocks you care about

Most recent public disclosures: AI-powered summaries of the latest corporate filings

151
1
Nu-Med Plus, Inc. Nu-Med Plus Reports Improved Net Loss of $68,345 for Fiscal Year 2024

Via official filing (AI summary) | 4 days ago | 0 comments

152
1
LFTD PARTNERS INC. LFTD Partners Inc. Reports $1.86 Million Net Loss and Decrease in Net Sales for 2024

Via official filing (AI summary) | 4 days ago | 0 comments

153
1
OMNIQ Corp. OMNIQ Corp. Reports $73.6 Million Revenue Decline and Improved Net Loss for Fiscal Year 2024

Via official filing (AI summary) | 4 days ago | 0 comments

154
1
Calidi Biotherapeutics, Inc. Calidi Biotherapeutics Reports $22.2 Million Net Loss for 2024, Decreased R&D Expenses

Via official filing (AI summary) | 4 days ago | 0 comments

155
1
LSEB Creative Corp. LSEB Creative Corp. Reports $3.3M in Sales and $57K Net Loss for December 2024 Quarter

Via official filing (AI summary) | 4 days ago | 0 comments

156
1
SCIENTIFIC INDUSTRIES INC Scientific Industries Reports $6.4 Million Net Loss for Fiscal Year 2024

Via official filing (AI summary) | 4 days ago | 0 comments

157
1
Interactive Strength, Inc. Interactive Strength Inc. Reports 459% Revenue Increase to $5.38 Million for 2024

Via official filing (AI summary) | 4 days ago | 0 comments

158
1
Xos, Inc. Xos, Inc. Reports $55.96 Million Revenue with 26% Growth, Faces Financial Challenges

Via official filing (AI summary) | 4 days ago | 0 comments

159
1
byNordic Acquisition Corp byNordic Acquisition Corporation Reports $206K Net Loss for Fiscal Year 2024

Via official filing (AI summary) | 4 days ago | 0 comments

160
1
MESA ROYALTY TRUST/TX Mesa Royalty Trust Reports 80% Decline in Royalty Income for Fiscal Year 2024

Via official filing (AI summary) | 4 days ago | 0 comments

161
1
Babcock & Wilcox Enterprises, Inc. Babcock & Wilcox Reports $717.3M Revenue Decline, Increases Operating Income

Via official filing (AI summary) | 4 days ago | 0 comments

162
1
Super League Enterprise, Inc. Super League Enterprise Reports 35% Revenue Decline and $16.6 Million Net Loss for Fiscal Year 2024

Via official filing (AI summary) | 4 days ago | 0 comments

163
1
Provident Bancorp, Inc. /MD/ Provident Bancorp Reports $7.3 Million Net Income, 33.8% Decrease for Fiscal Year 2024

Via official filing (AI summary) | 4 days ago | 0 comments

164
1
VASO Corp Vaso Corporation Reports $86.8 Million Revenue with Decline in Net Income for Fiscal Year 2024

Via official filing (AI summary) | 4 days ago | 0 comments

165
1
ADM ENDEAVORS, INC. ADM Endeavors Reports 11% Revenue Growth to $5.76 Million for Fiscal Year 2024

Via official filing (AI summary) | 4 days ago | 0 comments

166
1
Onconova Therapeutics, Inc. Onconova Therapeutics Reports $166.5 Million Net Loss and Financial Challenges in 2024

Via official filing (AI summary) | 4 days ago | 0 comments

167
1
RetinalGenix Technologies Inc. RetinalGenix Technologies Reports $4.32 Million Net Loss and Seeks Funding for Product Development

Via official filing (AI summary) | 4 days ago | 0 comments

168
1
Cartesian Growth Corp II Cartesian Growth Corporation II Reports Decrease in Net Income to $8.2 Million for Fiscal Year 2024

Via official filing (AI summary) | 4 days ago | 0 comments

169
1
REGO PAYMENT ARCHITECTURES, INC. REGO Payment Architectures Reports $11.6 Million Net Loss for Fiscal Year 2024

Via official filing (AI summary) | 4 days ago | 0 comments

170
1
Avalon GloboCare Corp. Avalon GloboCare Reports 52.7% Reduction in Net Losses for Fiscal Year 2024

Via official filing (AI summary) | 4 days ago | 0 comments

171
1
Carisma Therapeutics Inc. Carisma Therapeutics Reports $60.5M Net Loss for 2024, Collaboration Revenues Increase

Via official filing (AI summary) | 4 days ago | 0 comments

172
1
FIRST CAPITAL INC First Capital, Inc. Reports Decrease in Net Income for Fiscal Year 2024

Via official filing (AI summary) | 4 days ago | 0 comments

173
1
Humacyte, Inc. Humacyte Reports $148.7 Million Net Loss for 2024, FDA Approves Symvess™

Via official filing (AI summary) | 4 days ago | 0 comments

174
1
Scilex Holding Co Scilex Holding Company Reports $72.8 Million Net Loss for 2024, Revenue Increases to $56.6 Million

Via official filing (AI summary) | 4 days ago | 0 comments

175
1
Galera Therapeutics, Inc. Galera Therapeutics Reports Decline in Financial Performance and Strategic Acquisition of Nova Pharmaceuticals

Via official filing (AI summary) | 4 days ago | 0 comments